HLB Life Science Co., Ltd.

₩2,555As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:067630Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (0.87%)
Div yield —
ROE (11.11%)
Medical Distribution
Beta (5Y) 0.15
PE TTM —
TSR TTM (39.17%)
Mkt cap ₩311.3B
ROIC (5.24%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,911
13.93%
(11.08%)
Hold 1|4|9|7|4
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
35.26
34.80
35.14
34.40
5.30%
(3.18%)
2.48%
(2.38%)
Revenue₩B
24.10
23.80
23.61
23.41
12.01%
10.74%
3.90%
0.28%
Peers (US$229.5M)
Cap (US$)
PE
236.3M
—
227.4M
7.838x
215.8M
13.63x
Capital
TTM
5Y
10Y
Leveragex
4.029
(0.045)
(0.048)
EBIT/Intx
2.095
1.029
0.985
Own earn%
(18.66)
(46.92)
(34.94)
Sh yield%
59.29
34.02
34.06
Owners
Insiders/Inst%
6.72
61.94
Short interest%
2.49
SBC / revenue%
1.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
18–23
$1 testx
0.0
Incr. ROIC%
10